Managed care, hospice use, site of death, and medical expenditures in the last year of life

被引:131
|
作者
Emanuel, EJ
Ash, A
Yu, W
Gazelle, G
Levinsky, NG
Saynina, O
McClellan, M
Moskowitz, M
机构
[1] NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA
[2] Natl Bur Econ Res, Palo Alto, CA USA
[3] Harvard Vanguard Med Associates, Palliat & Support Med Program, Boston, MA USA
[4] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[5] Boston Univ, Sch Med, Gen Internal Med Sect, Hlth Care Res Unit, Boston, MA 02118 USA
关键词
D O I
10.1001/archinte.162.15.1722
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We examined deaths of Medicare beneficiaries in Massachusetts and California to evaluate the effect of managed care on the use of hospice and site of death and to determine how hospice affects the expenditures for the last year of life. Methods: Medicare data for beneficiaries in Massachusetts (n=37933) and California (n=27685) who died in 1996 were merged with each state's death certificate files to determine site and cause of death. Expenditure data were Health Care Financing Administration payments and were divided into 30-day periods from the date of death back 12 months. Results: In Massachusetts, only 7% of decedents were enrolled in managed care organizations (MCOs); in California, 28%. More than 60% of hospice users had cancer. Hospice use was much lower in Massachusetts than in California (12% vs 18%). In both states, decedents enrolled in MCOs used hospice care much more than those enrolled in fee-for-service plans (17% vs 11% in Massachusetts and 25% vs 15% in California). This pattern persisted for those with cancer and younger (aged 65-74 years) decedents. Decedents receiving hospice care were significantly (P<.001 for both) less likely to die in the hospital (11% vs 43% in Massachusetts and 5% vs 43% in California). Enrollment in MCOs did not affect the proportion of in-hospital deaths (those enrolled in fee-for-service plans vs MCOs: 40% vs 39% in Massachusetts; and 37% vs 34% in California). Expenditures in the last year of life were $28 588 in Massachusetts and $27 814 in California; about one third of the expenditures occurred in the last month before death. Hospital services accounted for more than 50% of all expenditures in both states, despite 77% of decedents being hospitalized in Massachusetts and just 55% being hospitalized in California. Among patients with cancer, expenditures were 13% to 20% lower for those in hospice. Conclusions: Medicare-insured decedents in California were more than 4 times more likely to be enrolled in MCOs, were 50% more likely to use a hospice, and had a 30% lower hospitalization rate than decedents in Massachusetts, yet there are few differences in out-of-hospital deaths or expenditures in the last year of life. However, patients with cancer using hospice did have significant savings.
引用
收藏
页码:1722 / 1728
页数:7
相关论文
共 50 条
  • [1] Influence of age on medicare expenditures and medical care in the last year of life
    Levinsky, NG
    Yu, W
    Ash, A
    Moskowitz, M
    Gazelle, G
    Saynina, O
    Emanuel, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (11): : 1349 - 1355
  • [2] Managed care and the growth of medical expenditures
    Cutler, DM
    Sheiner, L
    [J]. FRONTIERS IN HEALTH POLICY RESEARCH 1, 1998, 1 : 77 - 115
  • [3] Comparison of Japanese Centenarians' and Noncentenarians' Medical Expenditures in the Last Year of Life
    Nakanishi, Yasuhiro
    Tsugihashi, Yukio
    Akahane, Manabu
    Noda, Tatsuya
    Nishioka, Yuichi
    Myojin, Tomoya
    Kubo, Shinichiro
    Higashino, Tsuneyuki
    Okuda, Naoko
    Robine, Jean-Marie
    Imamura, Tomoaki
    [J]. JAMA NETWORK OPEN, 2021, 4 (11)
  • [4] Managed care and medical expenditures of Medicare beneficiaries
    Chernew, Michael
    DeCicca, Philip
    Town, Robert
    [J]. JOURNAL OF HEALTH ECONOMICS, 2008, 27 (06) : 1451 - 1461
  • [5] MEDICAL EXPENDITURES OF TERMINAL CANCER-PATIENTS DURING THE LAST YEAR OF LIFE
    LONG, SH
    GIBBS, JO
    CROZIER, JP
    COOPER, DI
    NEWMAN, JF
    LARSEN, AM
    [J]. INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 1984, 21 (04) : 315 - 327
  • [6] The last month of life: continuity, care site and place of death
    Sahlberg-Blom, E
    Ternestedt, BM
    Johansson, JE
    [J]. PALLIATIVE MEDICINE, 1998, 12 (04) : 287 - 296
  • [7] Socioeconomic status and medical care expenditures in medicare managed care
    Kapur, Kanika
    Rogowski, Jeannette A.
    Freedman, Vicki A.
    Wickstrom, Steven L.
    Adams, John L.
    Escarce, Jose J.
    [J]. JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2006, 17 (04) : 876 - 898
  • [8] Medication use in the last year of life: a cross-sectional hospice study
    Scullion, Liam
    Dodds, Hope
    Liu, Qinghao
    Hunt, Mary Elizabeth
    Gordon, Simon
    Todd, Adam
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (E6) : E740 - E743
  • [9] Association of long-term care needs, approaching death and age with medical and long-term care expenditures in the last year of life: An analysis of insurance claims data
    Mori, Hiroko
    Ishizaki, Tatsuro
    Takahashi, Ryutaro
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2020, 20 (04) : 277 - 284
  • [10] What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program?
    Taylor, Donald H., Jr.
    Ostermann, Jan
    Van Houtven, Courtney H.
    Tulsky, James A.
    Steinhauser, Karen
    [J]. SOCIAL SCIENCE & MEDICINE, 2007, 65 (07) : 1466 - 1478